| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | HNF1a |
| Uniprot No | P20823 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-631aa |
| 氨基酸序列 | MVSKLSQLQT ELLAALLESG LSKEALIQAL GEPGPYLLAG EGPLDKGESC GGGRGELAEL PNGLGETRGS EDETDDDGED FTPPILKELE NLSPEEAAHQ KAVVETLLQE DPWRVAKMVK SYLQQHNIPQ REVVDTTGLN QSHLSQHLNK GTPMKTQKRA ALYTWYVRKQ REVAQQFTHA GQGGLIEEPT GDELPTKKGR RNRFKWGPAS QQILFQAYER QKNPSKEERE TLVEECNRAE CIQRGVSPSQ AQGLGSNLVT EVRVYNWFAN RRKEEAFRHK LAMDTYSGPP PGPGPGPALP AHSSPGLPPP ALSPSKVHGV RYGQPATSET AEVPSSSGGP LVTVSTPLHQ VSPTGLEPSH SLLSTEAKLV SAAGGPLPPV STLTALHSLE QTSPGLNQQP QNLIMASLPG VMTIGPGEPA SLGPTFTNTG ASTLVIGLAS TQAQSVPVIN SMGSSLTTLQ PVQFSQPLHP SYQQPLMPPV QSHVTQSPFM ATMAQLQSPH ALYSHKPEVA QYTHTGLLPQ TMLITDTTNL SALASLTPTK QVFTSDTEAS SESGLHTPAS QATTLHVPSQ DPAGIQHLQP AHRLSASPTV SSSSLVLYQS SDSSNGQSHL LPSNHSVIET FISTQMASSS Q |
| 预测分子量 | 67,3 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是与HNF1α重组蛋白相关的3篇参考文献的简要信息：
1. **《Recombinant HNF1α protein purification and DNA-binding characterization》**
- 作者：Mendel, D.B. et al.
- 摘要：报道了在大肠杆菌中重组表达HNF1α蛋白的优化方法，通过亲和层析纯化获得高纯度蛋白，并利用电泳迁移实验(EMSA)验证其与靶DNA序列的特异性结合能力。
2. **《Structural insights into HNF1α dysfunction in monogenic diabetes》**
- 作者：Yamagata, K. et al.
- 摘要：通过X射线晶体学解析了重组HNF1α蛋白的DNA结合域结构，揭示了特定突变(如MODY3相关突变)如何破坏蛋白构象，导致转录活性丧失及糖尿病发生。
3. **《Functional analysis of HNF1α mutations using recombinant protein models》**
- 作者：Wang, H. et al.
- 摘要：在昆虫细胞系统中表达携带不同临床突变的HNF1α重组蛋白，发现部分突变体在二聚化或核定位能力上存在缺陷，为解释其致病机制提供了体外实验依据。
注：以上文献为示例性概括，具体内容需根据实际论文调整。建议通过PubMed或Web of Science以关键词"HNF1α recombinant"+"expression/purification/function"检索最新研究。
Hepatocyte Nuclear Factor 1-alpha (HNF1α) is a transcription factor critical for regulating gene expression in metabolic tissues, particularly the liver, pancreas, and kidneys. It binds to specific DNA sequences to control the transcription of genes involved in glucose metabolism, insulin secretion, and lipid homeostasis. Notably, HNF1α mutations are linked to maturity-onset diabetes of the young type 3 (MODY3), a monogenic form of diabetes characterized by impaired insulin production. This association underscores its role in maintaining pancreatic β-cell function and glucose sensing.
Recombinant HNF1α protein is engineered in vitro using expression systems like *E. coli* or mammalian cell cultures. The protein typically retains functional domains: an N-terminal DNA-binding domain with a POU-homeodomain for sequence recognition and dimerization, and a C-terminal transactivation domain for recruiting transcriptional co-regulators. Purification methods often involve affinity tags (e.g., His-tag) followed by chromatography, ensuring high purity and activity. Activity validation includes electrophoretic mobility shift assays (EMSA) or luciferase reporter assays to confirm DNA-binding and transcriptional activation capabilities.
Research applications of recombinant HNF1α span mechanistic studies of diabetes pathogenesis, *in vitro* modeling of gene regulatory networks, and drug discovery. It serves as a tool to investigate interactions with cofactors (e.g., HNF1β or DCoH) or mutations disrupting DNA binding, aiding in therapeutic target identification. Additionally, it enables high-throughput screening for compounds modulating HNF1α activity, potentially restoring transcriptional dysregulation in metabolic disorders. Its structural analysis via crystallography or cryo-EM further elucidates mutation impacts on protein-DNA interfaces. Overall, recombinant HNF1α bridges molecular insights into metabolic diseases and translational applications in diagnostics and therapeutics.
×
